vs
Side-by-side financial comparison of bioAffinity Technologies, Inc. (BIAF) and KOSS CORP (KOSS). Click either name above to swap in a different company.
KOSS CORP is the larger business by last-quarter revenue ($2.9M vs $1.6M, roughly 1.8× bioAffinity Technologies, Inc.). KOSS CORP runs the higher net margin — -19.8% vs -197.0%, a 177.2% gap on every dollar of revenue. On growth, KOSS CORP posted the faster year-over-year revenue change (-19.6% vs -27.8%). KOSS CORP produced more free cash flow last quarter ($-1.1M vs $-2.6M). Over the past eight quarters, KOSS CORP's revenue compounded faster (4.2% CAGR vs -18.6%).
bioAffinity Technologies, Inc. is a clinical-stage biotechnology firm focused on developing non-invasive in vitro diagnostic tests for early detection of cancer and respiratory diseases. It serves global healthcare markets, with a core mission to deliver accessible, high-accuracy diagnostic solutions that improve patient outcomes and reduce overall healthcare system costs.
Koss Corporation is a company in Milwaukee, Wisconsin, US that manufactures headphones. The company created the first high-fidelity stereo headphones in 1958.
BIAF vs KOSS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.6M | $2.9M |
| Net Profit | $-3.1M | $-565.4K |
| Gross Margin | — | 29.0% |
| Operating Margin | -196.9% | -35.5% |
| Net Margin | -197.0% | -19.8% |
| Revenue YoY | -27.8% | -19.6% |
| Net Profit YoY | -5.7% | -700.6% |
| EPS (diluted) | $-3.59 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6M | $2.9M | ||
| Q3 25 | $1.4M | $4.1M | ||
| Q2 25 | $1.3M | $3.1M | ||
| Q1 25 | $1.9M | $2.8M | ||
| Q4 24 | $2.2M | $3.6M | ||
| Q3 24 | $2.4M | $3.2M | ||
| Q2 24 | $2.4M | $2.9M | ||
| Q1 24 | $2.4M | $2.6M |
| Q4 25 | $-3.1M | $-565.4K | ||
| Q3 25 | $-5.1M | $243.7K | ||
| Q2 25 | $-4.1M | $-232.7K | ||
| Q1 25 | $-2.7M | $-316.7K | ||
| Q4 24 | $-3.0M | $94.1K | ||
| Q3 24 | $-2.0M | $-419.5K | ||
| Q2 24 | $-2.1M | $-110.4K | ||
| Q1 24 | $-2.0M | $-313.8K |
| Q4 25 | — | 29.0% | ||
| Q3 25 | — | 40.0% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 39.0% | ||
| Q4 24 | — | 39.5% | ||
| Q3 24 | — | 36.6% | ||
| Q2 24 | — | 40.4% | ||
| Q1 24 | — | 31.9% |
| Q4 25 | -196.9% | -35.5% | ||
| Q3 25 | -158.6% | -1.1% | ||
| Q2 25 | -198.2% | -14.2% | ||
| Q1 25 | -141.7% | -18.7% | ||
| Q4 24 | -133.5% | -4.0% | ||
| Q3 24 | -84.0% | -19.9% | ||
| Q2 24 | -87.1% | -11.0% | ||
| Q1 24 | -80.8% | -23.1% |
| Q4 25 | -197.0% | -19.8% | ||
| Q3 25 | -349.3% | 6.0% | ||
| Q2 25 | -319.9% | -7.5% | ||
| Q1 25 | -143.5% | -11.4% | ||
| Q4 24 | -134.4% | 2.6% | ||
| Q3 24 | -85.1% | -13.1% | ||
| Q2 24 | -88.0% | -3.8% | ||
| Q1 24 | -81.5% | -11.9% |
| Q4 25 | $-3.59 | $-0.06 | ||
| Q3 25 | $-4.74 | $0.03 | ||
| Q2 25 | $-0.17 | $-0.02 | ||
| Q1 25 | $-0.16 | $-0.03 | ||
| Q4 24 | $-17.27 | $0.01 | ||
| Q3 24 | $-4.84 | $-0.05 | ||
| Q2 24 | $-0.19 | $-0.01 | ||
| Q1 24 | $-0.20 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.4M | $15.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.3M | $30.3M |
| Total Assets | $11.0M | $36.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | $15.5M | ||
| Q3 25 | $7.7M | $16.5M | ||
| Q2 25 | $802.8K | $15.7M | ||
| Q1 25 | $444.7K | $13.0M | ||
| Q4 24 | $1.1M | $9.7M | ||
| Q3 24 | $756.6K | $11.9M | ||
| Q2 24 | $801.3K | $14.9M | ||
| Q1 24 | $2.5M | $9.9M |
| Q4 25 | $7.3M | $30.3M | ||
| Q3 25 | $8.9M | $30.9M | ||
| Q2 25 | $-2.1M | $30.6M | ||
| Q1 25 | $1.4M | $30.7M | ||
| Q4 24 | $2.6M | $31.0M | ||
| Q3 24 | $3.1M | $30.8M | ||
| Q2 24 | $3.4M | $31.1M | ||
| Q1 24 | $5.3M | $31.1M |
| Q4 25 | $11.0M | $36.8M | ||
| Q3 25 | $11.5M | $37.7M | ||
| Q2 25 | $4.8M | $37.2M | ||
| Q1 25 | $5.5M | $37.3M | ||
| Q4 24 | $6.5M | $37.4M | ||
| Q3 24 | $6.6M | $38.1M | ||
| Q2 24 | $6.7M | $37.2M | ||
| Q1 24 | $8.0M | $37.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.6M | $-760.8K |
| Free Cash FlowOCF − Capex | $-2.6M | $-1.1M |
| FCF MarginFCF / Revenue | -160.7% | -37.5% |
| Capex IntensityCapex / Revenue | 0.0% | 10.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.4M | $-546.7K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.6M | $-760.8K | ||
| Q3 25 | $-2.5M | $762.6K | ||
| Q2 25 | $-2.6M | $-534.9K | ||
| Q1 25 | $-1.6M | $370.4K | ||
| Q4 24 | $-1.7M | $-252.0K | ||
| Q3 24 | $-1.7M | $201.6K | ||
| Q2 24 | $-1.5M | $-174.0K | ||
| Q1 24 | $-2.3M | $328.6K |
| Q4 25 | $-2.6M | $-1.1M | ||
| Q3 25 | $-2.5M | $761.5K | ||
| Q2 25 | $-2.7M | $-541.8K | ||
| Q1 25 | $-1.7M | $306.2K | ||
| Q4 24 | $-1.7M | $-314.3K | ||
| Q3 24 | $-1.7M | $-155.6K | ||
| Q2 24 | $-1.6M | $-174.8K | ||
| Q1 24 | $-2.4M | $269.3K |
| Q4 25 | -160.7% | -37.5% | ||
| Q3 25 | -171.8% | 18.7% | ||
| Q2 25 | -209.6% | -17.6% | ||
| Q1 25 | -91.3% | 11.0% | ||
| Q4 24 | -76.0% | -8.8% | ||
| Q3 24 | -73.1% | -4.9% | ||
| Q2 24 | -65.1% | -6.0% | ||
| Q1 24 | -99.2% | 10.2% |
| Q4 25 | 0.0% | 10.9% | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 1.1% | 0.2% | ||
| Q1 25 | 2.7% | 2.3% | ||
| Q4 24 | 0.0% | 1.8% | ||
| Q3 24 | 0.4% | 11.2% | ||
| Q2 24 | 1.2% | 0.0% | ||
| Q1 24 | 1.7% | 2.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.13× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -2.68× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
